Oxypeucedanin hydrate helps with rheumatoid arthritis
Author Information
Author(s): Liu Mengdan, Huo Xueyan, Li Congcong, Hu Yunjie, Lei Haoran, Wang Dong, Zhu Lin, Gu Yucheng, Guo Dale, Huang Lijun, Deng Yun
Primary Institution: Chengdu University of Traditional Chinese Medicine
Hypothesis
Can oxypeucedanin hydrate (OXH) effectively alleviate rheumatoid arthritis (RA) symptoms by inhibiting the TLR4-MD2/NF-κB/MAPK signaling pathway?
Conclusion
Oxypeucedanin hydrate significantly alleviates symptoms of rheumatoid arthritis in a rat model by inhibiting inflammation through the TLR4-MD2/NF-κB/MAPK pathway.
Supporting Evidence
- OXH treatment reduced levels of inflammatory factors like TNF-α, IL-6, and IL-1β in macrophages.
- OXH improved body weight and reduced swelling in collagen-induced arthritis rats.
- OXH inhibited the activation of the NF-κB/MAPK pathway in both in vitro and in vivo models.
- Transcriptome analysis showed significant changes in gene expression related to inflammation after OXH treatment.
Takeaway
A natural compound called oxypeucedanin hydrate can help reduce swelling and pain in arthritis by stopping certain signals in the body that cause inflammation.
Methodology
The study used LPS-induced RAW264.7 macrophages and a collagen-induced arthritis model in rats to evaluate the anti-inflammatory effects of OXH.
Limitations
The study primarily focused on animal models, and further clinical trials are needed to confirm the findings in humans.
Participant Demographics
60 male Wistar rats were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website